Role of PDGF in fibrotic diseases and systemic sclerosis.
about
Pathologic and molecular profiling of rapid-onset fibrosis and inflammation induced by multi-walled carbon nanotubesThe immune pathogenesis of scleroderma: context is everythingCurrent perspectives on the immunopathogenesis of systemic sclerosisRoles of Proteoglycans and Glycosaminoglycans in Wound Healing and FibrosisUnderstanding and Managing Pregnancy in Patients with LupusCellular targeting in autoimmunityUnique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targetsTransition from inflammation to proliferation: a critical step during wound healingSystemic Sclerosis and the Gastrointestinal Tract-Clinical ApproachAnimal models of systemic sclerosis: their utility and limitations.Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disordersPlatelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts.Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.A unifying hypothesis for scleroderma: identifying a target cell for scleroderma.PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptorsThe role of total and cartilage-specific estrogen receptor alpha expression for the ameliorating effect of estrogen treatment on arthritis.RNA interference against platelet-derived growth factor receptor α mRNA inhibits fibroblast transdifferentiation in skin lesions of patients with systemic sclerosis.Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trialExperimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts.Elevated transforming growth factor β and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblastsA one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung diseasePathogenesis of Systemic Sclerosis.PDGF mediates TGFβ-induced migration during development of the spinous process.Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trialPDGFRβ expression and function in fibroblasts derived from pluripotent cells is linked to DNA demethylation.Lipotransfer for radiation-induced skin fibrosis.PDGF-BB Promotes Type I IFN-Dependent Vascular Alterations and Monocyte Recruitment in a Model of Dermal Fibrosis.Molecular and cellular mechanisms of pulmonary fibrosis.Progenitors of secondary crest myofibroblasts are developmentally committed in early lung mesoderm.CD44 promotes the migration of bone marrow-derived mesenchymal stem cells toward gliomaA recurrent PDGFRB mutation causes familial infantile myofibromatosis.Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.Mechanisms of vascular damage in systemic sclerosis.Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.PDGFRα Is a Key Regulator of T1 and T3's Differential Effect on SMA Expression in Human Corneal Fibroblasts.Bleomycin induces upregulation of lysyl oxidase in cultured human fetal lung fibroblastsDeconstructing fibrosis research: do pro-fibrotic signals point the way for chronic dermal wound regeneration?Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?Biomarkers for skin involvement and fibrotic activity in scleroderma.The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis.
P2860
Q23914873-D6A5D7E8-F375-47F3-B7B9-90AA541F227DQ24633658-8C1A2382-0C4B-4714-AE8B-958324033EB9Q26741264-5D843DB2-0B59-4400-8718-93C793B893F2Q26786042-0FAD13C0-053B-4A5F-BFE6-8D502BB94C6DQ26798179-612ABEB9-6FBA-4920-9DDC-A19E93A20CFFQ26824580-667538E7-B140-41F4-8351-D719F0BCE019Q27675037-5FB92167-15FE-4A91-8E42-7547872A5564Q28068273-24311267-F128-4825-8A64-CF002D5150B8Q28079598-905C746A-5D7F-4054-A268-12E285E23311Q28390528-1E8B224D-B5D9-4866-A0F2-24330CF03A28Q29048615-DA14A1A9-825F-4EE2-9B33-9765962FD4CDQ29347051-4F194309-44A6-4112-A92F-C8CC7971436BQ30250273-B0357A12-43A4-469F-9ED4-57BD3BC73551Q33889221-51F6EDED-5BD1-4B27-B86A-0B14A06B6E2BQ34295402-BEF4E490-CDC1-4592-A144-63F00A1411D3Q34480349-59335146-9D1C-4CEA-9069-ED678AD2CDD9Q34663751-68796FE7-5DA7-4B27-B7F0-FD3E11FCB6AEQ34906164-D1D682B3-0404-4743-A8CF-4996CEAFF87BQ34995163-E4280CA1-4DAD-4D82-9DFE-22BA2A334023Q35142313-F3283C85-49FF-4371-8A36-66EF62A6D1EDQ35489187-D33407FB-AF9A-411E-80B8-4B66DCF16D24Q35693212-D7815252-7941-4F3F-AC07-0787DADC5B13Q35877961-0BA89A42-6BDB-4D61-8284-12A1CA820749Q35961706-CC0D2DD7-8DD7-4FF2-94A0-874A3BB5E27EQ36010393-4189E444-7B01-4720-A74F-8A0279265E35Q36015057-9FE9218C-D239-4F08-A9BD-D108C91703CBQ36130126-8AFEDD25-0DBB-40FD-9A92-3FC99BAF1653Q36237168-CDE8FC72-0336-4098-9500-DA240259B7DFQ36294358-264A63C9-F3B2-408E-AA19-EF3C0706A25AQ36741362-1D3847AD-06D8-4004-A624-90A493DD2EFFQ36909279-1364CF2F-2DC7-4EA4-9FB5-C1EFAA02DAB9Q37224668-D0127809-B6E7-4171-844C-60DAA8E93F11Q37622943-A29F3246-9D96-40A8-A85F-C2E86F3F87D6Q37656327-AADA42DB-793A-4989-9FA5-69BABC7ADF10Q37682516-C1277DA8-A0D6-4A37-A321-E2007C27134AQ37728816-0DFF2B7C-2CEF-42FE-8702-095A42F24DCBQ37866690-7D8BF9B1-5D7F-488E-9ED1-E5F64DC9602CQ37894728-7F562D1E-964D-40C6-BDA8-1CAFC16EF173Q37912251-AA22E50C-3EEB-4C1E-A3C8-021787CC6253Q38042445-C4925BEF-789D-4EF8-BEFE-64D364E16823
P2860
Role of PDGF in fibrotic diseases and systemic sclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of PDGF in fibrotic diseases and systemic sclerosis.
@en
Role of PDGF in fibrotic diseases and systemic sclerosis.
@nl
type
label
Role of PDGF in fibrotic diseases and systemic sclerosis.
@en
Role of PDGF in fibrotic diseases and systemic sclerosis.
@nl
prefLabel
Role of PDGF in fibrotic diseases and systemic sclerosis.
@en
Role of PDGF in fibrotic diseases and systemic sclerosis.
@nl
P2860
P356
P1433
P1476
Role of PDGF in fibrotic diseases and systemic sclerosis.
@en
P2860
P356
10.1093/RHEUMATOLOGY/KEN265
P478
47 Suppl 5
P577
2008-10-01T00:00:00Z